SLC25A47 and hepatocellular carcinoma: In HepG2 human hepatoma cells that have endogenous SLC25A47, the mitochondrial NAD+ content was similarly unaltered by SLC25A47 overexpression (Fig. 1j) and consistently decreased by the silencing of SLC25A51 but not SLC25A47 (Fig. 1k).